{
    "2018-03-05": [
        [
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业投资策略：年报密集期 精选业绩预期强烈估值合理的细分龙头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "年报",
                        "业绩预期",
                        "估值合理",
                        "细分龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业2018年3月份投资月报：创新药2.0+细分市场龙头",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资月报",
                        "创新药",
                        "细分市场",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业业绩快报点评:降价因素逐步消化,看好长期成长性",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "业绩快报",
                        "降价因素",
                        "长期成长性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}